HomeProducts › Cardiology › ES Invigour 33gm Powder

ES Invigour 33gm Powder

Salt Composition: FOOD SUPPLEMENT

₹1737.00₹1930.87

Inclusive of all taxes

Categories: Cardiology

Conditions: Nutrient Deficiency

Product Introduction

ES Invigour powder is a specially formulated supplement designed to address malnutrition and gastrointestinal issues in patients with cancer undergoing treatment. It contains 26 micronutrients and macronutrients formulated to meet the nutritional requirements of patients with cancer. The soluble fibre and adequate protein content with high PDCAAS score support gut health in patients undergoing cancer treatment. Key amino acids including BCAA and L-Glutamine, along with energy-providing nutrients such as L-carnitine, Taurine, Inositol and Choline, function as dietary support for patients with cancer throughout their treatment course. ES Invigour Powder is also suitable for patients with diabetes and is safe for diabetic patients. It can be used as tube feed only under strict direction of a physician or dietician. This supplement is not for medicinal use and does not prevent or cure any disease condition. Do not consume ES Invigour powder if you are allergic to any of its ingredients. Before taking the supplement, consult your doctor if you are pregnant, planning to become pregnant, or think you may be pregnant, or if you are breastfeeding. Check with your doctor if you have a history of any disease. No common side effects have been observed with this supplement; if you notice any symptoms, contact your doctor immediately.

Uses

ES Invigour powder uses are: Dietary replacement through-out the duration of the treatment Support gut health

How it works

ES invigour powder has optimum nutrients which helps meet the dietary requirements of the cancer patient. The inulin present in the powder helps to attenuate transplantable melanoma tumour growth.

How to Use

Always take the ES invigour powder, 2 to 3 sachet per day or as suggested by your healthcare provider. Mix 1 sachet in 150 ml water and drink it immediately. Do not take more than the recommended ES Invigour sachet dosage.

Side Effects

ES Invigour powder side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. ES invigour powder is generally safe to consume and is not associated with significant side effects. However, consult your dietician if you experience any unfamiliar side effects.

References

  1. Emilie Boucher et al., Inulin prebiotic reinforces host cancer immunosurveillance via ɣδ T cell activation; Published on 17/02/2023; Accessed on 23/11/2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981629/#:~:text=Inulin%20is%20a%20widely%20consumed,%2B%20T%20cell%2Ddependent%20manner .
  2. Mary L. Hardy et al., Multivitamin/multimineral supplements for cancer prevention: implications for primary care practice; Published on 18/08/2014; Accessed on 23/11/2023 https://www.tandfonline.com/doi/abs/10.1080/00325481.2015.993284

Safety Advice

Pregnancy: Consult your doctor It is unknown whether ES invigour powder is harmful to the unborn baby. Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant.

Lungs: Consult your doctor It is unknown whether the ES invigour powder is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Breastfeeding: Consult your doctor It is unknown whether ES invigour powder is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS